Latest Information Update: 15 Apr 2004
At a glance
- Originator Sirus
- Class Antiemetics
- Mechanism of Action Serotonin 3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 15 Apr 2004 Discontinued - Preclinical for Emesis in United Kingdom (Sublingual)
- 30 Jun 2003 Preclinical trials in Emesis in United Kingdom (Sublingual)